ARCHIVES

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

This article is from The Cancer Letter archive.

Vol. 25 No. 19 | May 14, 1999

Download PDF Visit The Full Archive

Related Articles

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

Reauthorization Still Held up

September 30, 1988

CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions

May 6, 1983

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009